scholarly journals Evaluation of Epidemic Prevention Abilities for Severe Acute Respiratory Syndrome Coronavirus-2 and Middle East Respiratory Syndrome Coronavirus in South Korea

2021 ◽  
Vol 14 (6) ◽  
Author(s):  
Umar Saeed ◽  
Zahra Zahid Piracha ◽  
Sara Rizwan Uppal ◽  
Rizwan Uppal

: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) preferentially infects respiratory tract cells, but it has organotropism. Middle East respiratory syndrome coronavirus (MERS-CoV) is significantly distinct from common cold and SARS coronavirus. In past few years, the SARS-CoV-2 and MERS-CoV caused several deaths in South Korea. The aim of current study was to assess SARS-CoV-2 and MERS-CoV awareness and epidemic prevention ability in South Koreans.According to our results, out of 1500 participants, 98.8% and 64.3% were aware of SARS-CoV-2 and MERS-CoV, respectively. Moreover, 97% of the participants used masks for prevention of airborne diseases, while 65.3% of the participants reused the same mask for several days. In addition, 50% of the participants were not satisfied with the government support. Future viral epidemics can be prevented by disseminating advanced knowledge and awareness among general public.

2020 ◽  
Vol 1 (1) ◽  
pp. 1-4
Author(s):  
Richard Avoi ◽  
Syed Sharizman Syed Abdul Rahim ◽  
Mohammad Saffree Jeffree ◽  
Visweswara Rao Pasupuleti

  Since the Coronavirus disease 2019 (COVID-19) pandemic unfolded in China (Huang et al., 2020) back in December 2019, thus far, more than five million people were infected with the virus and 333,401 death were recorded worldwide (WHO, 2020b). The exponential increase in number shows that COVID-19 spreads faster compared to Severe Acute Respiratory Syndrome (SARS) or Middle East Respiratory Syndrome (MERS). A study (Zou et al., 2020) has shown that high viral loads of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are detected in symptomatic patients soon after the onset of symptoms, wherein the load content is higher in their nose than in their throat. Furthermore, the same study has revealed similar viral loads between symptomatic and asymptomatic patients. Therefore, these findings may suggest the possibility of COVID-19 transmission earlier before the onset of symptoms itself. In the early stages of the pandemic, the control measures carried out have focused on screening of symptomatic person; at the time, the whole world thought that the spread of SARS-Cov-2 would only occur through symptomatic person-to-person transmission. In comparison, transmission in SARS would happen after the onset of illness, whereby the viral loads in the respiratory tract peaked around ten days after the development of symptoms by patients (Peiris et al., 2003). However, case detection for SARS (i.e. screening of symptomatic persons) will be grossly inadequate for the current COVID-19 pandemic, thus requiring different strategies to detect those infected with SARS-CoV-2 before they develop the symptoms.


2021 ◽  
Vol 17 (8) ◽  
pp. e1009857
Author(s):  
Michelle N. Vu ◽  
Vineet D. Menachery

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility similar to common cold coronaviruses (CoVs). In this review, we briefly discuss the features of the receptor-binding domain (RBD) and protease cleavage of the SARS-CoV-2 spike protein that enable SARS-CoV-2 to be a pandemic virus.


2020 ◽  
Vol 15 (9) ◽  
pp. 625-648
Author(s):  
SK Manirul Haque ◽  
Omar Ashwaq ◽  
Abdulla Sarief ◽  
Abdul Kalam Azad John Mohamed

The coronavirus disease (COVID-19) was first identified in China, December 2019. Since then, it has spread the length and breadth of the world at an unprecedented, alarming rate. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which causes COVID-19, has much in common with its closest homologs, SARS-CoV and Middle East respiratory syndrome-CoV. The virus–host interaction of SARS-CoV-2 uses the same receptor, ACE2, which is similar to that of SARS-CoV, which spreads through the respiratory tract. Patients with COVID-19 report symptoms including mild-to-severe fever, cough and fatigue; very few patients report gastrointestinal infections. There are no specific antiviral strategies. A few strong medications are under investigation, so we have to focus on proposals which ought to be taken to forestall this infection in a living host.


2020 ◽  
Vol 35 (1-2) ◽  
Author(s):  
Pradeep Pagaria ◽  
L. R. Choudhary ◽  
Haridayal Choudhary ◽  
Ganga Ram ◽  
Turfan Khan

Coronavirus outbreak was first reported in Wuhan, China on 31 December, 2019. Coronavirus (CoV) is a large family of viruses that causes illness. It ranges from the common cold to more severe diseases like Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus is a new strain of virus that has not been identified in human so far.


Author(s):  
Sk Sarif Hassan ◽  
Atanu Moitra ◽  
Pabitra Pal Choudhury ◽  
Prasanta Pramanik ◽  
Siddhartha Jana

Coronaviruses are a large family of RNA viruses which cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. This article highlights some key findings based on a thorough scanning of genes of 470 SARS-CoV2 genomes, including the co-presence of ORF7a and ORF8 over the 251 SARS-CoV2 genomes and the absence of the gene ORF7b over the 219 SARS-CoV2 genomes collected from various countries including India.


Author(s):  
Sk Sarif Hassan ◽  
Atanu Moitra ◽  
Pabitra Pal Choudhury ◽  
Prasanta Pramanik ◽  
Siddhartha Sankar Jana

Coronaviruses are a large family of RNA viruses which cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. This article highlights some key findings based on a thorough scanning of genes of 475 SARS-CoV2 genomes, including the co-presence of ORF7a and ORF8 over the 256 SARS-CoV2 genomes and the absence of the gene ORF7b over the 219 SARS-CoV2 genomes collected from various countries including India. The presence of the gene ORF7b is found in the SARS-CoV2 genomes containing the L-type strain which is reported to having much higher virulence as compared to the S-type strain.


2017 ◽  
Vol 1 (3) ◽  
pp. 4
Author(s):  
Dewi Murniati

Coronavirus memiliki famili besar yang menyebabkan penyakit pada manusia dan hewan. Pada manusia dapat menyebabkan penyakit dengan gejala mulai dari common cold sampai Severe Acute Respiratory Syndrome (SARS)


2021 ◽  
Vol 9 (1) ◽  
pp. 50-56
Author(s):  
Dian Permata Sari

Corona viruses (CoV) are part of a family of viruses that cause illnesses ranging from the flu to more severe illnesses such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). This virus can be transmitted from person to person through small droplets from the nose or mouth when coughing, sneezing or speaking. Because the spread of this virus is very fast, it requires fast handling so that this virus does not spread, one of which is by implementing health protocols, namely maintaining distance, washing hands and using masks. All provinces in Indonesia have not been spared from this virus, including the province of West Sumatra. Classification of the spread of this virus is necessary in order to break the chain of its spread. One of the techniques used in this grouping is k-means, which uses several groups to assign multiple data to a partition system. The results of this study indicate that the regions in the first cluster have the highest rates of positive cases and patients who die, while the areas in the second and third clusters have the potential for the spread of Covid-19 which is also a concern of the government.


Sign in / Sign up

Export Citation Format

Share Document